Cell and Gene Therapy CMO and CDMO Facilities
Searchable and sortable database of 188 Cell and Gene Therapy CMOs / CDMOs worldwide as of 12 Sept. 2020, including 140 companies and 48 academic or government facilities.
This is a global database of facilities that provide (mostly or exclusively) services as contract manufacturing organizations (CMO) and/or contract development and manufacturing organizations (CDMO) for the cell and gene therapy industry worldwide.
Included: Manufacturers of therapeutic cell products (unmodified or gene-modified), iPS cell lines for therapeutic products, viral vectors and DNA plasmids for cell and gene therapy industry.
Excluded: Contract research organizations (CROs) not performing manufacture of the therapeutic product, vendors of supplies (reagents, devices, etc.)
For each company:
- Facility name
- Link to facility website if available
- Country of origin
- CMO/CDMO service expertise
- Mergers & Acquisitions, Notes
- The excel file has separate lists for CMO/CDMO that are Industry versus Academic/ Government facilities.
Our last release in March 2020 held 174 companies. Since then, we have added 16 organizations (14 industry companies and 2 academic/government) and removed 2 organizations due to acquisitions.
Geographically, our January 2020 database held 69 facilities operating in North America (40%), 69 in Europe (40%), and 35 (20%) in Asia. We had 173 locations for the 161 facilities in our Jan. 2020 database because some of the companies have laboratories in more than one country.
|SAMPLE Cell and Gene Therapy CMO and CDMO Facilities||11.3 KB|